Receive The Newest Study Notifications

Combination trial to evaluate safety and anti-tumor activity of agents that target B-cell cancers ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), today announced...

Patient recruitment and retention is currently a challenging and consistent problem in clinical trials. This issue can result in increased costs, depleted resources and even delay introduction to the market. When conducting a clinical trial, there are some common tips...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a world leader in development and commercialization of cellular medicines, announced today that the last patient has now been dosed in the Phase 3 events-driven trial of its allogeneic cell therapy product candidate Revascor...

Gliknik Inc. today announced that it will receive a $15 million milestone payment from Pfizer Inc. (NYSE: PFE) following the start of a Phase I clinical trial of Pfizer drug candidate PF-06755347, previously known as GL-2045, for the potential treatment of chronic...

California-based Vascular Dynamics, Inc. (VDI) announced that it is sponsoring a new clinical trial, called CALM-2 ( C ontrolling A nd L owering blood pressure with M obiusHD®), of a novel endovascular approach to treat patients with drug-resistant hypertension. St....

Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a companion diagnostic, today announced that the Tigris clinical trial has been approved by the US...

Full researcher access to Spire Health Tag’s continuous respiration, heart rate, sleep and activity data Spire Health, the market leader in continuous respiration sensing and high-adherence ambulatory monitoring, is announcing the availability of its Research...

CytoDyn Inc. (OTC.QB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody, leronlimab (PRO 140), for multiple therapeutic indications, announced that its new laboratory located in Philadelphia under the leadership of Professor Richard...

CASI Pharmaceuticals, Inc.(Nasdaq: CASI), a U.S. based pharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China, U.S., and throughout the world, today announced that the National...

Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, presented updated preliminary safety and efficacy data from its ongoing...

Cancer clinical trials are an important option for patients with cancer. Yet, once a trial ends, patients still need care plans. Little is known at what point during clinical trial transitions to initiate advance planning discussions or how to educate research teams...

NephCure Kidney International (NephCure), a not-for-profit organization focused on accelerating research for effective treatments for rare forms of Nephrotic Syndrome, announced today the launch of a newly designed patient-centric website, KidneyHealthGateway.com; a...

Elayta Crossed Blood Brain Barrier and Reached CNS Levels Associated in Preclinical Studies with Cognitive Improvement Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in...

Verisense was designed specifically to improve data quality in clinical trials, while reducing burden on sponsors, sites and participants Shimmer, a global leader in wearable technology for research applications, today announced the launch of Verisense, its...

Greenphire and the Society for Clinical Research Sites (SCRS) release data that identifies challenges throughout the clinical study lifecycle, from budget negotiation through patient engagement and reimbursement  Greenphire, the global leader in financial software for...

Comprehend Systems, Inc., the leader in Clinical Intelligence solutions, will highlight a new approach to clinical risk management at SCOPE 2019, the annual summit for clinical ops executives. The event takes place on February 19–20, 2019. Comprehend's CEO and...

Clinical sites seek couples to enroll in year-long study of pregnancy prevention The Population Council, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Los Angeles Biomedical Research Institute, and University of...

Vivacelle Bio, Inc. today announces that the US. Food and Drug Administration (FDA) has granted it an Investigational New Drug (IND) clearance to proceed with its phase IIa clinical trial of the safety and efficacy of VBI-1. VBI-1 is a paradigm-changing cardiovascular...

Teckro has raised a fresh round of funding to accelerate its aim of helping to bring drugs and treatments to market quicker and more efficiently. The $25 million Series C round was led by Northpond Ventures with participation from Founders Fund, Sands Capital...

Inventiva Announces Results From Phase IIb Clinical Trial with Lanifibranor in Systemic Sclerosis Primary endpoint of the trial was not met, no statistically significant difference between the placebo and lanifibranor treated groups for the primary outcome Favorable...